Yan Chen

USPTO Granted Patents = 50 (Patent Applications = 32)

EPO Patents = 26 (Patent Applications = 40)

Average Co-Inventor Count = 4.6

ph-index = 8

Forward Citations = 329(Granted Patents)

Forward Citations (Not Self Cited) = 289(Oct 12, 2025)

Location History:

Wallingford, CT (US) (2014 - 2022)
Lexington, MA (US) (2010 - 2023)
Yardley, PA (US) (2021 - 2023)
Seattle, WA (US) (2021 - 2024)

Company Filing History:

16 out of 3,681

Bristol-myers Squibb Compnay

Juno Therapeutics Gmbh

patents

4. 5 out of 42

Viiv Healthcare UK (no.5) Limited

patents

5. 4 out of 8

Viiv Healthcare UK (no. 4) Limited

Memorial Sloan Kettering Cancer Center

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428486 - Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides (2025-09-30),

2. 11919970 - Antibodies and chimeric antigen receptors specific for ROR1 (2024-03-05),

3. 11827714 - Antibodies and chimeric antigen receptors specific for CD19 (2023-11-28),

4. 11814441 - Bi-specific antigen-binding polypeptides (2023-11-14),

5. 11718601 - Pyridinyl substituted oxoisoindoline compounds (2023-08-08),

6. 11629434 - Antibody screening methods (2023-04-18),

7. 11623961 - Antibodies and chimeric antigen receptors specific for B-cell maturation antigen (2023-04-11),

8. 11464790 - Triterpenoids with HIV maturation inhibitory activity (2022-10-11),

9. 11414784 - Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes (2022-08-16),

10. 11339388 - Methods and compositions for generation of binding agents against cell surface antigens (2022-05-24),

11. 11268090 - X-display complexes for protein screening methods (2022-03-08),

12. 11166959 - Isofuranone compounds useful as HPK1 inhibitors (2021-11-09),

13. 11136398 - PDGF receptor beta binding polypeptides (2021-10-05),

14. 11084845 - C-3 and C-17 modified triterpenoids as HIV-1 inhibitors (2021-08-10),

15. 11066475 - Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides (2021-07-20),

Title: Inventor Yan Chen - Pioneering Innovations in Lexington, MA

Introduction: Yan Chen is a visionary inventor based in Lexington, MA, known for her groundbreaking contributions to various technological fields.

Latest Patents: Yan Chen holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing her diverse range of expertise and innovation.

Career Highlights: With over two decades of experience in research and development, Yan Chen has led numerous successful projects that have resulted in cutting-edge inventions with real-world applications.

Collaborations: Throughout her career, Yan Chen has collaborated with top research institutions, leading companies, and universities, fostering a culture of innovation and knowledge-sharing.

Conclusion: Yan Chen's passion for innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.